Global Diuretic Drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	137 Pages	TechNavio	July, 2024	INF19033647

Best Price Guarantee
Price	from $2,500
Length	137 Pages
Publisher	TechNavio
Published Date	July, 2024
SKU	INF19033647

Global Diuretic Drugs Market 2024-2028

The diuretic drugs market is forecasted to grow by USD 78 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the diuretic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of hypertension among people, increasing drug distribution through online channels, and increasing geriatric population.

Technavio's diuretic drugs market is segmented as below:

By Product Type

Loop diuretics
Thiazide diuretics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing kidney diseases as one of the prime reasons driving the diuretic drugs market growth during the next few years. Also, development of oral nanoparticle delivery mechanism and increased high investments in r and d activities in diuretics will lead to sizable demand in the market.

The report on the diuretic drugs market covers the following areas:

Diuretic drugs market sizing
Diuretic drugs market forecast
Diuretic drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diuretic drugs market vendors that include AbbVie Inc., Akorn Operating Co. LLC, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd.. Also, the diuretic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Diuretic Drugs Market 2018 - 2022; Historic Market Size - Data Table on Global Diuretic Drugs Market 2018 - 2022 ($ million); 4.2 Product Type segment analysis 2018 - 2022; Historic Market Size - Product Type Segment 2018 - 2022 ($ million); 4.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product Type: 6.1 Market segments; Chart on Product Type - Market share 2023-2028 (%); Data Table on Product Type - Market share 2023-2028 (%); 6.2 Comparison by Product Type; Chart on Comparison by Product Type; Data Table on Comparison by Product Type; 6.3 Loop diuretics - Market size and forecast 2023-2028; Chart on Loop diuretics - Market size and forecast 2023-2028 ($ million); Data Table on Loop diuretics - Market size and forecast 2023-2028 ($ million); Chart on Loop diuretics - Year-over-year growth 2023-2028 (%); Data Table on Loop diuretics - Year-over-year growth 2023-2028 (%); 6.4 Thiazide diuretics - Market size and forecast 2023-2028; Chart on Thiazide diuretics - Market size and forecast 2023-2028 ($ million); Data Table on Thiazide diuretics - Market size and forecast 2023-2028 ($ million); Chart on Thiazide diuretics - Year-over-year growth 2023-2028 (%); Data Table on Thiazide diuretics - Year-over-year growth 2023-2028 (%); 6.5 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Product Type; Market opportunity by Product Type ($ million); Data Table on Market opportunity by Product Type ($ million)
7 Customer Landscape: 7.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 8.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 8.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 8.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 8.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 8.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 8.8 Denmark - Market size and forecast 2023-2028; Chart on Denmark - Market size and forecast 2023-2028 ($ million); Data Table on Denmark - Market size and forecast 2023-2028 ($ million); Chart on Denmark - Year-over-year growth 2023-2028 (%); Data Table on Denmark - Year-over-year growth 2023-2028 (%); 8.9 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 8.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 8.11 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 8.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 11.4 Alembic Pharmaceuticals Ltd.; Alembic Pharmaceuticals Ltd. - Overview; Alembic Pharmaceuticals Ltd. - Product / Service; Alembic Pharmaceuticals Ltd. - Key offerings; 11.5 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; 11.6 Hikma Pharmaceuticals Plc; Hikma Pharmaceuticals Plc - Overview; Hikma Pharmaceuticals Plc - Business segments; Hikma Pharmaceuticals Plc - Key news; Hikma Pharmaceuticals Plc - Key offerings; Hikma Pharmaceuticals Plc - Segment focus; 11.7 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 11.8 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 11.9 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; 11.10 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; 11.11 Validus Pharmaceuticals LLC; Validus Pharmaceuticals LLC - Overview; Validus Pharmaceuticals LLC - Product / Service; Validus Pharmaceuticals LLC - Key offerings; 11.12 VITARIS AG; VITARIS AG - Overview; VITARIS AG - Product / Service; VITARIS AG - Key offerings
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 12.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Parent Market; Exhibits10: Data Table on - Parent Market; Exhibits11: Market characteristics analysis; Exhibits12: Value Chain Analysis; Exhibits13: Offerings of companies included in the market definition; Exhibits14: Market segments; Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Historic Market Size - Data Table on Global Diuretic Drugs Market 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Product Type Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Product Type - Market share 2023-2028 (%); Exhibits31: Data Table on Product Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Product Type; Exhibits33: Data Table on Comparison by Product Type; Exhibits34: Chart on Loop diuretics - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Loop diuretics - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Loop diuretics - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Loop diuretics - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Thiazide diuretics - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Thiazide diuretics - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Thiazide diuretics - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Thiazide diuretics - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Product Type ($ million); Exhibits47: Data Table on Market opportunity by Product Type ($ million); Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits51: Chart on Geographic comparison; Exhibits52: Data Table on Geographic comparison; Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Denmark - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Denmark - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Denmark - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Denmark - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits89: Market opportunity By Geographical Landscape ($ million); Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits91: Impact of drivers and challenges in 2023 and 2028; Exhibits92: Overview on criticality of inputs and factors of differentiation; Exhibits93: Overview on factors of disruption; Exhibits94: Impact of key risks on business; Exhibits95: Companies covered; Exhibits96: Matrix on companies position and classification; Exhibits97: AbbVie Inc. - Overview; Exhibits98: AbbVie Inc. - Product / Service; Exhibits99: AbbVie Inc. - Key news; Exhibits100: AbbVie Inc. - Key offerings; Exhibits101: Alembic Pharmaceuticals Ltd. - Overview; Exhibits102: Alembic Pharmaceuticals Ltd. - Product / Service; Exhibits103: Alembic Pharmaceuticals Ltd. - Key offerings; Exhibits104: Aurobindo Pharma Ltd. - Overview; Exhibits105: Aurobindo Pharma Ltd. - Product / Service; Exhibits106: Aurobindo Pharma Ltd. - Key offerings; Exhibits107: Hikma Pharmaceuticals Plc - Overview; Exhibits108: Hikma Pharmaceuticals Plc - Business segments; Exhibits109: Hikma Pharmaceuticals Plc - Key news; Exhibits110: Hikma Pharmaceuticals Plc - Key offerings; Exhibits111: Hikma Pharmaceuticals Plc - Segment focus; Exhibits112: Novartis AG - Overview; Exhibits113: Novartis AG - Business segments; Exhibits114: Novartis AG - Key news; Exhibits115: Novartis AG - Key offerings; Exhibits116: Novartis AG - Segment focus; Exhibits117: Pfizer Inc. - Overview; Exhibits118: Pfizer Inc. - Product / Service; Exhibits119: Pfizer Inc. - Key news; Exhibits120: Pfizer Inc. - Key offerings; Exhibits121: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits122: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits123: Sun Pharmaceutical Industries Ltd. - Key news; Exhibits124: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits125: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits126: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits127: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits128: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits129: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits130: Validus Pharmaceuticals LLC - Overview; Exhibits131: Validus Pharmaceuticals LLC - Product / Service; Exhibits132: Validus Pharmaceuticals LLC - Key offerings; Exhibits133: VITARIS AG - Overview; Exhibits134: VITARIS AG - Product / Service; Exhibits135: VITARIS AG - Key offerings; Exhibits136: Inclusions checklist; Exhibits137: Exclusions checklist; Exhibits138: Currency conversion rates for US$; Exhibits139: Research methodology; Exhibits140: Information sources; Exhibits141: Data validation; Exhibits142: Validation techniques employed for market sizing; Exhibits143: Data synthesis; Exhibits144: 360 degree market analysis; Exhibits145: List of abbreviations